|
CLTB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.550190E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.077920E-02 |
| Normal-vs-Stage2 |
2.232800E-01 |
| Normal-vs-Stage3 |
9.941400E-01 |
| Normal-vs-Stage4 |
2.069000E-01 |
| Stage1-vs-Stage2 |
5.762800E-01 |
| Stage1-vs-Stage3 |
1.305540E-02 |
| Stage1-vs-Stage4 |
3.590100E-04 |
| Stage2-vs-Stage3 |
2.553200E-01 |
| Stage2-vs-Stage4 |
3.736200E-02 |
| Stage3-vs-Stage4 |
2.473800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.652500E-02 |
| Normal-vs-AfricanAmerican |
1.022300E-02 |
| Normal-vs-Asian |
9.172600E-01 |
| Caucasian-vs-AfricanAmerican |
1.38890000001002E-06 |
| Caucasian-vs-Asian |
8.508400E-01 |
| AfricanAmerican-vs-Asian |
4.722000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.059980E-01 |
| Normal-vs-Female |
4.389800E-01 |
| Male-vs-Female |
4.133800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.431600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.338200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.517980E-01 |
| Normal-vs-Age(81-100Yrs) |
2.955000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.303200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.174400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.796800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.111600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.713800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.787700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.106400E-02 |
| Normal-vs-Grade 2 |
1.144370E-03 |
| Normal-vs-Grade 3 |
5.805600E-01 |
| Normal-vs-Grade 4 |
8.599200E-03 |
| Grade 1-vs-Grade 2 |
9.877600E-01 |
| Grade 1-vs-Grade 3 |
2.669800E-01 |
| Grade 1-vs-Grade 4 |
1.360960E-03 |
| Grade 2-vs-Grade 3 |
1.721500E-03 |
| Grade 2-vs-Grade 4 |
7.93340004801024E-09 |
| Grade 3-vs-Grade 4 |
6.186800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.25299999557072E-08 |
| Normal-vs-ccB subtype |
6.421600E-01 |
| ccA subtype-vs-ccB subtype |
3.98499999998414E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.221700E-02 |
| Normal-vs-N1 |
9.468000E-01 |
| N0-vs-N1 |
4.489000E-01 |
|
|
